Genetic Risk and Cancer Estimation Study

Overview

About this study

The purpose of this research is to develop a collection of known mutation carriers to analyze cancer risk and long-term clinical outcomes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Eligible particiants 18 and older.
  • Either a family or personal history of cancer and/or a family or personal history of genetic variants in cancer predisposition genes.
  • Participants may also be those who have tested negatively for genetic variants in cancer predisposition genes.

Exclusion Criteria:

  • This project does not involve prisoners or children.

Eligibility last updated 6/23/23. Questions regarding updates should be directed to the study team contact.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Fergus Couch, Ph.D.

Open for enrollment

Contact information:

Rachel Mensink

(855) 511-3952

GRACEStudy@mayo.edu

La Crosse, Wis.

Mayo Clinic principal investigator

Caroline Clune, M.D.

Open for enrollment

Contact information:

Leandra Pake CCRP

(608) 392-9719

Franzen.Leandra@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions